{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T10:37:51Z","timestamp":1776422271902,"version":"3.51.2"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2002,9,1]],"date-time":"2002-09-01T00:00:00Z","timestamp":1030838400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2002,9,1]],"date-time":"2002-09-01T00:00:00Z","timestamp":1030838400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2002,9]]},"DOI":"10.1023\/a:1024487604631","type":"journal-article","created":{"date-parts":[[2003,9,15]],"date-time":"2003-09-15T13:22:37Z","timestamp":1063632157000},"page":"351-356","source":"Crossref","is-referenced-by-count":33,"title":["Lower urinary tract symptoms, pain and quality of life assessment in chronic non-bacterial prostatitis patients treated with \u03b1-blocking agent doxazosin; versus placebo"],"prefix":"10.1007","volume":"34","author":[{"given":"Yal\u00e7\u0131n","family":"Evliyao\u011flu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Refik","family":"Burgut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"5119587_CR1","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/S0022-5347(17)36966-5","volume":"148","author":"MJ Barry","year":"1992","unstructured":"Barry MJ, Fowler FJ Jr, O'Leary MP et al. The American Urological Association symptom index for benign prostatic hyperplasia. J Urol 1992; 148: 1549\u20131557.","journal-title":"J Urol"},{"key":"5119587_CR2","first-page":"553","volume-title":"The 2nd International Consultation on Benign Prostatic Hyperplasia (BPH)","author":"ATK Cockett","year":"1993","unstructured":"Cockett ATK, Aso Y, Denis L et al. Recommendations of the International Consensus Committee concerning: (1) Prostate symptom score (I-PSS) and quality of life assessment. (2) Diagnostic work-up of patients presenting with symptoms suggestive of prostatism. (3) Standardization of the evaluation of treatment modalities. (4) BPH treatment recommendations. In: Cockett ATK, Khoury S, Aso Y et al., eds. The 2nd International Consultation on Benign Prostatic Hyperplasia (BPH). Channel Islands: Scientific Communication International Ltd., 1993: 553\u2013564."},{"key":"5119587_CR3","first-page":"231A","volume":"147","author":"DE Neal Jr","year":"1992","unstructured":"Neal DE Jr, Moon TD. Clinical trials of terazosin in non-bacterial prostatitis. J Urol (Part 2) 1992; 147: 231A (abstract 72).","journal-title":"J Urol (Part 2)"},{"key":"5119587_CR4","first-page":"492","volume":"5","author":"EM Meares","year":"1968","unstructured":"Meares EM, Stamey TA. Bacteriologic localization patterns in bacterial prostatitis and urethritis. Invest Urol 1968; 5: 492\u2013518.","journal-title":"Invest Urol"},{"key":"5119587_CR5","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/0090-4295(93)90332-5","volume":"42","author":"H Lepor","year":"1993","unstructured":"Lepor H and Machi G. Comparison of AUA symptom index in unselected males and females between fifty-five and seventy-nine years of age. Urology 1993; 42: 36\u201340.","journal-title":"Urology"},{"key":"5119587_CR6","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1016\/S0022-5347(01)64702-5","volume":"157","author":"M Kojima","year":"1997","unstructured":"Kojima M, Naya Y, Inoue W et al. The American Urological Association symptom index for Benign Prostatic Hyperplasia as a function of age volume and ultrasonic appearance of the prostate. J Urol 1997; 157: 2160\u20132165.","journal-title":"J Urol"},{"key":"5119587_CR7","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1016\/S0022-5347(01)64707-4","volume":"157","author":"LS Marks","year":"1997","unstructured":"Marks LS, Partin AW, Gormley GJ et al. Prostate tissue composition and response to finasteride in men with symptomatic benign prostatic hyperplasia. J Urol 1997; 157: 2171\u20132178.","journal-title":"J Urol"},{"key":"5119587_CR8","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/S0022-5347(17)32309-1","volume":"152","author":"SA Kaplan","year":"1994","unstructured":"Kaplan SA, Te AE, Jacobs BZ. Urodynamic evidence of vesical neck obstruction in men with misdiagnosed chronic non-bacterial prostatitis and the therapeutic role of endoscopic incision of the bladder neck. J Urol 1994; 152: 2063\u20132065.","journal-title":"J Urol"},{"key":"5119587_CR9","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1016\/S0022-5347(01)64727-X","volume":"157","author":"SA Kaplan","year":"1997","unstructured":"Kaplan SA, Santarosa RP, D'Alisera PM et al. Pseudo-dyssynergia (contraction of the external sphincter during voiding) misdiagnosed as chronic non-bacterial prostatitis and the role of biofeedback as a therapeutic option. J Urol 1997; 157: 2234\u20132237.","journal-title":"J Urol"},{"key":"5119587_CR10","doi-asserted-by":"crossref","first-page":"525","DOI":"10.2165\/00003495-198835050-00003","volume":"35","author":"RA Young","year":"1988","unstructured":"Young RA, Brogden RN. Doxazosin: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy mild to moderate hypertension. Drugs 1988; 35: 525\u2013541.","journal-title":"Drugs"},{"key":"5119587_CR11","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0022-5347(01)67240-9","volume":"154","author":"A Fawzy","year":"1995","unstructured":"Fawzy A, Braun K, Lewis GP et al. Doxazosin in the treatment of benign prostatic hyperplasia in normotensive patients: a multicenter study. J Urol 1995; 154: 105\u2013109.","journal-title":"J Urol"},{"key":"5119587_CR12","first-page":"434A","volume":"149","author":"RS Kirby","year":"1993","unstructured":"Kirby RS, Chapple CR, Christmas TJ. Doxazosin minimal blood pressure effects in normotensive BPH patients. J Urol (Part 2) 1993; 149: 434A (abstract 886).","journal-title":"J Urol (Part 2)"},{"key":"5119587_CR13","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/pros.2990200402","volume":"20","author":"E Shapiro","year":"1992","unstructured":"Shapiro E, Hartanto V, Lepor H. Anti-desmin vs anti-actin for quantifying the area density of prostate smooth muscle. Prostate 1992; 20: 259\u2013267.","journal-title":"Prostate"},{"key":"5119587_CR14","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1476-5381.1992.tb14527.x","volume":"107","author":"T Tsujii","year":"1992","unstructured":"Tsujii T, Azuma H, Yamaguchi T, Oshima H. A possible role of decreased relaxation mediated by \u03b1-adrenoceptors in bladder outlet obstruction by benign prostatic hyperplasia. Br J. Pharmacol 1992; 107: 803\u2013807.","journal-title":"Br J. Pharmacol"},{"key":"5119587_CR15","first-page":"29","volume":"168","author":"RS. Kirby","year":"1995","unstructured":"Kirby RS. Efficacy of doxazosin in normotensive and hypertensive patients with benign prostatic hyperplasia. Scand J Urol Nephrol Suppl 1995; 168: 29\u201333.","journal-title":"Scand J Urol Nephrol Suppl"},{"key":"5119587_CR16","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0022-5347(01)65193-0","volume":"157","author":"H Lepor","year":"1997","unstructured":"Lepor H, Kaplan SA, Klimberg I et al. Doxazosin for benign prostatic hyperplasia: long term efficacy and safety in hypertensive and normotensive patients. J Urol 1997; 157: 525\u2013530.","journal-title":"J Urol"},{"key":"5119587_CR17","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0022-5347(01)63761-3","volume":"159","author":"GA Barbalias","year":"1998","unstructured":"Barbalias GA, Nikiforidis G, Liatsikos EN. \u03b1-Blockers for the treatment of chronic prostatitis in combination with anti-biotics. J Urol 1998; 159: 883\u2013887.","journal-title":"J Urol"},{"key":"5119587_CR18","first-page":"207","volume-title":"Therapy of Prostatitis","author":"EM Meares Jr.","year":"1986","unstructured":"Meares EM Jr. Prostatodynia: clinical findings and rationale for treatment. In: Weidner W, Brunner H, Krause W, Rothauge CF, eds. Therapy of Prostatitis. San Francisco: W. Zuckschwerdt Verlag, 1986; (11): 207\u2013212."},{"key":"5119587_CR19","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/0090-4295(90)80214-8","volume":"36","author":"GA. Barbalias","year":"1990","unstructured":"Barbalias GA. Prostatodynia or painful male urethral syndrome? Urology 1990; 36: 146\u2013153.","journal-title":"Urology"},{"key":"5119587_CR20","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/S0022-5347(01)66870-8","volume":"154","author":"JE Lowentritt","year":"1995","unstructured":"Lowentritt JE, Kawahara K, Human LG et al. Bacterial infection in prostatodynia. J Urol 1995; 154: 1378\u20131381.","journal-title":"J Urol"},{"key":"5119587_CR21","first-page":"32","volume":"8","author":"A. Shafik","year":"1998","unstructured":"Shafik A. Pudental canal syndrome: a new etiological factor in prostatodynia and its treatment by pudental decompression. Pain Dig 1998; 8: 32\u201338.","journal-title":"Pain Dig"},{"key":"5119587_CR22","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/0090-4295(94)90231-3","volume":"43","author":"DE Neal","year":"1994","unstructured":"Neal DE, Moon TD. Use of terazosin in prostatodynia and validation of a symptom score questionnaire. Urology 1994; 43: 460\u2013465.","journal-title":"Urology"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1024487604631.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1024487604631\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1024487604631.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T05:44:33Z","timestamp":1754891073000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1024487604631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,9]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,9]]}},"alternative-id":["5119587"],"URL":"https:\/\/doi.org\/10.1023\/a:1024487604631","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,9]]}}}